Cargando…

Evolution of Liver Transplantation Over the Last 2 Decades Based on a Single-Center Experience of 300 Cases

BACKGROUND: Over the past 2 decades, there have been many medical advances in the field of liver transplantation. We conducted this study to evaluate the changes in liver transplantation over the last 2 decades. MATERIAL/METHODS: Three hundred cases of liver transplantation encountered between 1997...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soyama, Akihiko, Hara, Takanobu, Matsushima, Hajime, Imamura, Hajime, Yamashita, Mampei, Adachi, Tomohiko, Miuma, Satoshi, Miyaaki, Hisamitsu, Nakao, Kazuhiko, Eguchi, Susumu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10656782/ https://www.ncbi.nlm.nih.gov/pubmed/37957951 http://dx.doi.org/10.12659/AOT.941796

Ejemplares similares

Long‐term outcomes of living‐donor liver transplantation, hepatic resection, and local therapy for hepatocellular carcinoma with three <3‐cm nodules in a single institute
por: Hidaka, Masaaki, et al.
Publicado: (2022)

The Kupffer Cell Number Affects the Outcome of Living Donor Liver Transplantation from Elderly Donors
por: Hidaka, Masaaki, et al.
Publicado: (2016)

Most Cases of Cryptogenic Cirrhosis May Be Nonobese Nonalcoholic Steatohepatitis - Risk Factors of Liver Steatosis After Liver Transplantation for Cryptogenic Cirrhosis: A Retrospective Study
por: Fukushima, Masanori, et al.
Publicado: (2022)

Living donor liver transplantation for a patient with acute liver failure following thyroid storm: a case report
por: Nagakawa, Kantoku, et al.
Publicado: (2023)

Association Between Trough Level of Tacrolimus and Change in Estimated Glomerular Filtration Rate 1 Year After Living Donor Liver Transplantation
por: Muta, Kumiko, et al.
Publicado: (2021)

Management of Spontaneous Portosystemic Shunts in 231 Patients Who Underwent Living Donor Liver Transplantation: A Retrospective Study from a Single Center in Nagasaki, Japan
por: Hamada, Takashi, et al.
Publicado: (2022)

Serum wisteria floribunda agglutinin-positive human Mac-2 binding protein is unsuitable as a diagnostic marker of occult hepatocellular carcinoma in end-stage liver cirrhosis
por: Nagakawa, Kantoku, et al.
Publicado: (2023)

Transplantation of chemically-induced liver progenitor cells ameliorates hepatic fibrosis in mice with diet-induced nonalcoholic steatohepatitis
por: Murakami, Shunsuke, et al.
Publicado: (2022)

Fully covered metallic stents for anastomotic biliary strictures after living donor liver transplantation
por: Komatsu, Naohiro, et al.
Publicado: (2023)

Liver transplantation for intrahepatic and hilar cholangiocellular carcinoma: Most recent updates in the literature
por: Eguchi, Susumu, et al.
Publicado: (2022)

Three-dimensional human bile duct formation from chemically induced human liver progenitor cells
por: Li, Peilin, et al.
Publicado: (2023)

Elevated Fasting Plasma Glucose before Liver Transplantation is Associated with Lower Post-Transplant Survival
por: Katsura, Emi, et al.
Publicado: (2016)

A Multi-Facility, Randomized, Comparative Study Examining the Efficacy of Biliary Reconstruction Under a Surgical Microscope in Living Donor Liver Transplantation
por: Soyama, Akihiko, et al.
Publicado: (2021)

Percutaneous Direct Puncture of Retropancreatic Splenic Vein and Portal Thrombectomy in a Patient With Liver Transplantation and Simultaneous Splenectomy
por: Hara, Takanobu, et al.
Publicado: (2022)

Comparative study of the effect of neuromuscular electrical stimulation and oral administration of branched-chain amino acid on preventing sarcopenia in patients after living-donor liver transplantation: study protocol for an open-label randomized controlled trial
por: Haraguchi, Masafumi, et al.
Publicado: (2021)

Living donor liver transplantation from a donor previously treated with interferon for hepatitis C virus: a case report
por: Hidaka, Masaaki, et al.
Publicado: (2011)

Early graft calcification without graft dysfunction after living donor liver transplantation: two case reports
por: Li, Peilin, et al.
Publicado: (2021)

Angioplasty of the inferior vena cava with a bovine pericardial patch by the modified open-chest dorsal approach for Budd-Chiari syndrome: A case report
por: Soyama, Akihiko, et al.
Publicado: (2023)

Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma
por: Sasaki, Ryu, et al.
Publicado: (2022)

The Contribution of Serum Complement Component 3 Levels to 90-Day Mortality in Living Donor Liver Transplantation
por: Fukui, Saeko, et al.
Publicado: (2021)

Corrigendum: The Contribution of Serum Complement Component 3 Levels to 90-Day Mortality in Living Donor Liver Transplantation
por: Fukui, Saeko, et al.
Publicado: (2022)

Prediction of Liver Prognosis from Pre-Transplant Renal Function Adjusted by Diuretics and Urinary Abnormalities in Adult-to-Adult Living Donor Liver Transplantation
por: Kitamura, Mineaki, et al.
Publicado: (2020)

Intrahepatic MicroRNA Profile of Liver Transplant Recipients with Hepatitis C Virus Co-Infected with Human Immunodeficiency Virus
por: Miyaaki, Hisamitsu, et al.
Publicado: (2017)

Shunt occlusion prior to lenvatinib administration prevents hepatic encephalopathy and hyperammonemia
por: Kuwahara, Ai, et al.
Publicado: (2020)

Blood carnitine profiling on tandem mass spectrometry in liver cirrhotic patients
por: Miyaaki, Hisamitsu, et al.
Publicado: (2020)

The impact of single-nucleotide polymorphisms on liver stiffness and controlled attenuation parameter in patients treated with direct-acting antiviral drugs for hepatitis C infection
por: Matsumoto, Kosuke, et al.
Publicado: (2022)

Impact of lenvatinib on renal function compared to sorafenib for unresectable hepatocellular carcinoma
por: Sasaki, Ryu, et al.
Publicado: (2022)

Hypoglycemia measured by flash glucose monitoring system predicts liver-related events in chronic liver disease patients
por: Sasaki, Ryu, et al.
Publicado: (2023)

Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice
por: Senoo, Takemasa, et al.
Publicado: (2018)

The Long-term Efficacy of Sodium Glucose Co-transporter 2 Inhibitor in Patients with Non-alcoholic Fatty Liver Disease
por: Yamashima, Mio, et al.
Publicado: (2019)

Inferior Vena Cava Anomalies with Portal Vein System Continuation Presenting as Portal Hypertension with a Long-term Follow-up
por: Fukushima, Masanori, et al.
Publicado: (2020)

A Donor Age-Based and Graft Volume–Based Analysis for Living Donor Liver Transplantation in Elderly Recipients
por: Imamura, Hajime, et al.
Publicado: (2017)

Peripheral lymphocyte fluctuation as an indicator of severe immune‐related adverse events in patients treated with immune checkpoint inhibitors
por: Haraguchi, Masafumi, et al.
Publicado: (2023)

Living Donor Liver Transplantation for Wilson’s Disease Associated with Fulminant Hepatic Failure: A Case Report
por: Huang, Yu, et al.
Publicado: (2018)

Intractable Hepatic Encephalopathy with a Large Portosystemic Shunt Successfully Treated Using Shunt-preserving Disconnection of the Portal and Systemic Circulation
por: Haraguchi, Masafumi, et al.
Publicado: (2020)

Influence of Interferon-free Direct-acting Antiviral Therapy on Primary Hepatocellular Carcinoma Recurrence: A Landmark Time Analysis and Time-dependent Extended Cox Proportional Hazards Model Analysis
por: Miuma, Satoshi, et al.
Publicado: (2020)

Initial and advanced endoscopic findings of monomorphic epitheliotropic intestinal T‐cell lymphoma in the duodenum: A case report
por: Fukushima, Masanori, et al.
Publicado: (2022)

Two difficulty diagnosis cases of severe veno-occlusive disease
por: Miyaaki, Hisamitsu, et al.
Publicado: (2013)

Surgical findings and technical knacks to performing living donor liver transplantation for hepatocellular carcinoma recurrence after carbon ion radiotherapy
por: Huang, Yu, et al.
Publicado: (2018)

Hepatitis C Virus Infection Increases c-Jun N-Terminal Kinase (JNK) Phosphorylation and Accentuates Hepatocyte Lipoapoptosis
por: Takaki, Hiroko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_v7cnpun6s4hffq27cpf1peq0h5